본문 바로가기
KERD
논문KCI 등재

The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome

Esra Sinem Kemer Doğan|Burak Doğan|Özlem Fentoğlu|Fatma Yeşim Kırzıoğlu
대한치주과학회 (The Korean Academy Of Periodontology)|2019.04|Journal of Periodontal & Implant Science|제49권 제2호|pp. 105-113|DOI 10.5051/jpis.2019.49.2.105

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

InflammationPeriodontal diseasesMetabolic syndrome XLipoxins
주제분류치의학

초록

Purpose: An unresolved inflammatory state contributes to the pathogenesis of periodontal disease and metabolic syndrome (MetS). Therefore, the purpose of this study was to evaluate the role of lipoxin A4 (LXA4), a proresolving lipid mediator, in the association between periodontal disease and MetS. Methods: Sixty-seven patients with MetS and 65 patients without MetS were included in the study. Sociodemographic information was obtained via a questionnaire, and detailed medical diagnoses were made. Periodontal parameters (plaque index [PI], gingival index [GI], probing pocket depth [PD], and clinical attachment level [CAL]) and metabolic parameters were measured, and serum LXA4 levels were determined. The associations among MetS, periodontal parameters, and serum LX levels were evaluated by adjusted multivariate linear regression analyses. Results: Patients with MetS were older and had a higher body mass index than patients without MetS. Periodontal parameters (PI, GI, PD, and CAL) were higher in patients with MetS than in those without MetS. Serum LXA4 levels were higher in patients without MetS. Multivariate linear regression analysis indicated a positive association between MetS and periodontal parameters (PD and CAL). Negative associations were established between MetS and LXA4 levels, and between LXA4 and periodontal parameters (PI, PD, and CAL). Conclusions: The presence of higher values of periodontal parameters in patients with MetS and the negative relationship of LXA4 with MetS and periodontal disease may support the protective role of proresolving lipid mediators in the association between periodontal disease and MetS.

Abstract

Purpose: An unresolved inflammatory state contributes to the pathogenesis of periodontal disease and metabolic syndrome (MetS). Therefore, the purpose of this study was to evaluate the role of lipoxin A4 (LXA4), a proresolving lipid mediator, in the association between periodontal disease and MetS. Methods: Sixty-seven patients with MetS and 65 patients without MetS were included in the study. Sociodemographic information was obtained via a questionnaire, and detailed medical diagnoses were made. Periodontal parameters (plaque index [PI], gingival index [GI], probing pocket depth [PD], and clinical attachment level [CAL]) and metabolic parameters were measured, and serum LXA4 levels were determined. The associations among MetS, periodontal parameters, and serum LX levels were evaluated by adjusted multivariate linear regression analyses. Results: Patients with MetS were older and had a higher body mass index than patients without MetS. Periodontal parameters (PI, GI, PD, and CAL) were higher in patients with MetS than in those without MetS. Serum LXA4 levels were higher in patients without MetS. Multivariate linear regression analysis indicated a positive association between MetS and periodontal parameters (PD and CAL). Negative associations were established between MetS and LXA4 levels, and between LXA4 and periodontal parameters (PI, PD, and CAL). Conclusions: The presence of higher values of periodontal parameters in patients with MetS and the negative relationship of LXA4 with MetS and periodontal disease may support the protective role of proresolving lipid mediators in the association between periodontal disease and MetS.

참고문헌 (40)

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
  2. Hajishengallis G, "Periodontitis: from microbial immune subversion to systemic inflammation", Nat Rev Immunol, 15, pp.30~44 (2015)
  3. Lockhart PB, "Bacteremia associated with toothbrushing and dental extraction", Circulation, 117, pp.3118~3125 (2008)
  4. Taylor JJ, "A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes", J Clin Periodontol, 40(Suppl 14), pp.S113~S134 (2013)
  5. Khader Y, "Periodontal status of patients with metabolic syndrome compared to those without metabolic syndrome", J Periodontol, 79, pp.2048~2053 (2008)
  6. Fukui N, "Periodontal status and metabolic syndrome in middleaged Japanese", J Periodontol, 83, pp.1363~1371 (2012)
  7. Nibali L, "Clinical review: association between metabolic syndrome and periodontitis: a systematic review and meta-analysis", J Clin Endocrinol Metab, 98, pp.913~920 (2013)
  8. Shimazaki Y, "Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study", J Dent Res, 86, pp.271~275 (2007)
  9. Li P, "Relationship of metabolic syndrome to chronic periodontitis", J Periodontol, 80, pp.541~549 (2009)
  10. Morita T, "A cohort study on the association between periodontal disease and the development of metabolic syndrome", J Periodontol, 81, pp.512~519 (2010)
  11. Thanakun S, "Association of untreated metabolic syndrome with moderate to severe periodontitis in Thai population", J Periodontol, 85, pp.1502~1514 (2014)
  12. Watanabe K, "Periodontal disease and metabolic syndrome: a qualitative critical review of their association", Arch Oral Biol, 59, pp.855~870 (2014)
  13. Forner L, "Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation", J Clin Periodontol, 33, pp.401~407 (2006)
  14. Ohnishi T, "Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes", J Periodontal Res, 44, pp.43~51 (2009)
  15. Rizzo M, "Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study", Cell Stress Chaperones, 17, pp.399~407 (2012)
  16. Das UN, "Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II", Clin Lipidol, 8, pp.465~480 (2013)
  17. Van Dyke TE, "Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases", J Dent Res, 82, pp.82~90 (2003)
  18. Serhan CN, "Novel anti-inflammatory--pro-resolving mediators and their receptors", Curr Top Med Chem, 11, pp.629~647 (2011)
  19. El Kebir D, "15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury", Am J Respir Crit Care Med, 180, pp.311~319 (2009)
  20. Yu D, "Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population", PLoS One, 10, pp.e0142848~ (2015)
  21. Doğan B, "Lipoxin A4 and neutrophil", lymphocyte ratio: a possible indicator in achieved systemic risk factors for periodontitis, 2015, pp.21, 2485~2493
  22. Tarannum F, "Association between lipoxin A4 and interleukin-12 in gingival crevicular fluid:a preliminary investigation", J Periodontal Res, 52, pp.210~217 (2017)
  23. Lütfioğlu M, "Gingival crevicular fluid interleukin-8 and lipoxin A4 levels of smokers and nonsmokers with different periodontal status: a cross-sectional study", J Periodontal Res, 51, pp.471~480 (2016)
  24. Van Dyke TE, "Proresolving nanomedicines activate bone regeneration in periodontitis", J Dent Res, 94, pp.148~156 (2015)
  25. Börgeson E, "Lipoxin A4 inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression", Infect Immun, 79, pp.1489~1497 (2011)
  26. Serhan CN, "Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators", J Immunol, 171, pp.6856~6865 (2003)
  27. Silness J, "Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition", Acta Odontol Scand, 22, pp.121~135 (1964)
  28. Loe H, "Periodontal disease in pregnancy. I. Prevalence and severity", Acta Odontol Scand, 21, pp.533~551 (1963)
  29. Armitage GC, "Development of a classification system for periodontal diseases and conditions", Ann Periodontol, 4, pp.1~6 (1999)
  30. Obesity: preventing and managing the global epidemic. Report of a WHO consultation, "WHO", World Health Organization, ~, pp.WHO technical report series 894 (2000)
  31. Ahn YB, "The association of hypertension with periodontitis is highlighted in female adults: results from the Fourth Korea National Health and Nutrition Examination Survey", J Clin Periodontol, 42, pp.998~1005 (2015)
  32. Lamster IB, "Periodontal disease and the metabolic syndrome", Int Dent J, 67, pp.67~77 (2017)
  33. Spite M, "Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases", Cell Metab, 19, pp.21~36 (2014)
  34. Börgeson E, "Lipoxin A4attenuates adipose inflammation", FASEB J, 26, pp.4287~4294 (2012)
  35. Van Dyke TE, "The management of inflammation in periodontal disease", J Periodontol, 79(Suppl), pp.1601~1608 (2008)
  36. Hasturk H, "Activation and resolution of periodontal inflammation and its systemic impact", Periodontol 2000, 69, pp.255~273 (2015)
  37. Morita T, "Association between periodontal disease and metabolic syndrome", J Public Health Dent, 69, pp.248~253 (2009)
  38. Kushiyama M, "Relationship between metabolic syndrome and periodontal disease in Japanese adults", J Periodontol, 80, pp.1610~1615 (2009)
  39. Nishimura F, "Periodontal disease as part of the insulin resistance syndrome in diabetic patients", J Int Acad Periodontol, 7, pp.16~20 (2005)
  40. Kim OS, "The severity of periodontitis and metabolic syndrome in Korean population: the Dong-gu study", J Periodontal Res, 53, pp.362~368 (2018)

이 간행물의 다른 논문 (6건)

PlagiarismSeung-Yun Shinpp. 59-59Long-term assessment of periodontal disease progression after surgical or non-surgical treatment: a systematic reviewJae-Kook Cha, Ignacio Sanz-Martín, Ignacio Sanz-Sánchez, 정의웅, 윤성욱pp. 60-75Evaluation of prognosis related to compliance with supportive periodontal treatment in patients with chronic periodontitis: a clinical retrospective study방은경, 이종빈, 김대엽, 신혜정pp. 76-89Periodontal regenerative therapy in endo-periodontal lesions: a retrospective study over 5 years정신혜, 한지영, 오소람pp. 90-104Improvement of the osteogenic potential of ErhBMP-2-/EGCG-coated biphasic calcium phosphate bone substitute: in vitro and in vivo activity김성태, 황재호, 오승한pp. 114-126
원문 보기